Rocket, Lab

Rocket Lab Shares Climb After Archimedes Vacuum Engine Test, While Insider Selling Tops $94 Million

Published on 07/14/2026 at 19:07 | Redaktion boerse-global.de

Shares gain 3.7% after successful Archimedes vacuum engine test, but remain 47.6% below 52-week high amid $896M insider selling and $8B Iridium takeover uncertainty.

Rocket Lab Stock Bounces on Engine Test as Insider Sales & Iridium Deal Loom
Rocket Lab Shares Climb After Archimedes Vacuum Engine Test, While Insider Selling Tops $94 Million Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

Rocket Lab’s stock found some relief on July 14 after the company successfully completed a long-duration burn test of its Archimedes vacuum engine (AVac) for the Neutron rocket’s upper stage. Shares traded at €70.10, a 3.7% gain from Monday’s close of €67.60, clawing back a fraction of the steep losses that had piled up over the prior week.

The bounce offered a brief reprieve from one of the sharpest downturns in recent months. The stock had fallen for five consecutive sessions, shedding roughly 19% and wiping out about $12 billion in market capitalization from its highs. On a 30-day view, the decline still stands at 25.74%, and even after the test-driven rally the share price remains 47.61% below the 52-week high of €133.80 reached on May 27.

The AVac engine test is a critical milestone for the Neutron programme. The vacuum-optimised version delivers roughly 20% more thrust than its first-stage counterpart and stands about 2.5 meters taller. To simulate high-altitude conditions, engineers used a "stub skirt" attachment during the burn. CEO Peter Beck has targeted the first Neutron launch for the fourth quarter of 2026. The 141-foot reusable rocket is designed to carry up to 13,000 kilograms to low Earth orbit and features a novel payload fairing dubbed "Hungry Hippo".

Should investors sell immediately? Or is it worth buying Rocket Lab?

But while the engineering progress earned a cheer from the market, the same trading session was overshadowed by the scale of insider selling. Between July 6 and July 8, the Equatorial Trust — a family foundation controlled by Beck — sold 3,275,779 shares in a series of open-market transactions. Beck himself personally disposed of an additional 986,197 shares on July 6 at an average price of $95.33, generating proceeds of roughly $94 million. Over the past 90 days, total insider sales at Rocket Lab have reached approximately $896 million, with Beck as the dominant seller. The trades were executed under a Rule 10b5-1 plan established in March 2026, meaning they were predetermined, but the sheer magnitude has weighed on sentiment.

The Iridium Communications takeover, valued at $8 billion in cash and stock, adds another layer of uncertainty. The deal includes a collar mechanism: if Rocket Lab’s stock trades between $67.50 and $112.50, Iridium shareholders will receive approximately $54 per share; below $67.50, the exchange ratio locks at 0.4000. Financing comes from a $3.6 billion bridge loan arranged by Deutsche Bank and Wells Fargo, due by June 28, 2027. Iridium brings 66 low-Earth-orbit satellites, about 2.5 million subscribers, and 2025 revenue of $871.7 million with a 57% EBITDA margin. Rocket Lab’s own backlog stands at $2.2 billion, including a $816 million missile-defense contract and 18 satellites for the Space Development Agency. For the first quarter, revenue grew 63% year-over-year, while trailing twelve-month revenue growth was 45.8%. The next quarterly update is scheduled for August 6.

Despite the operational wins — including a record-breaking VICTUS-HAZE mission for the U.S. Space Force — the stock remains burdened by profitability concerns. The operating margin is negative 33.2%, and the price-to-earnings ratio stands at minus 268.7. Analysts remain cautiously bullish: 13 of 16 covering the stock rate it a buy, three say hold, and the average price target is $113, with a range of $60 to $135. Morgan Stanley has an overweight rating with a base case of $105 and a bull case of $293, while Goldman Sachs is more cautious with a hold and $76 target.

Technically, the stock is flashing oversold signals. The relative strength index sits at 37.3, and the share price is 25.85% below its 50-day moving average of €94.54, though it remains 4.22% above the 200-day line at €67.26. Rocket Lab was added to the Nasdaq 100 on June 22, a milestone that has contributed to elevated volatility — the annualised volatility stands at 95.86%. The market capitalisation is approximately €44.36 billion, reflecting both the promise of a vertically integrated space company and the risks inherent in merging a high-growth rocket builder with a satellite communications operator during a period of insider liquidation.

Ad

Rocket Lab Stock: New Analysis - 14 July

Fresh Rocket Lab information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US7731211089 | ROCKET | boerse | 69768120 |